1. Home
  2. KRON vs FBLG Comparison

KRON vs FBLG Comparison

Compare KRON & FBLG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • KRON
  • FBLG
  • Stock Information
  • Founded
  • KRON 2017
  • FBLG 2021
  • Country
  • KRON United States
  • FBLG United States
  • Employees
  • KRON N/A
  • FBLG N/A
  • Industry
  • KRON Medicinal Chemicals and Botanical Products
  • FBLG
  • Sector
  • KRON Health Care
  • FBLG
  • Exchange
  • KRON Nasdaq
  • FBLG NYSE
  • Market Cap
  • KRON 41.5M
  • FBLG 37.1M
  • IPO Year
  • KRON 2020
  • FBLG 2024
  • Fundamental
  • Price
  • KRON $0.87
  • FBLG $0.70
  • Analyst Decision
  • KRON Buy
  • FBLG Strong Buy
  • Analyst Count
  • KRON 3
  • FBLG 4
  • Target Price
  • KRON $1.63
  • FBLG $13.00
  • AVG Volume (30 Days)
  • KRON 1.4M
  • FBLG 291.8K
  • Earning Date
  • KRON 08-07-2025
  • FBLG 08-06-2025
  • Dividend Yield
  • KRON N/A
  • FBLG N/A
  • EPS Growth
  • KRON N/A
  • FBLG N/A
  • EPS
  • KRON N/A
  • FBLG N/A
  • Revenue
  • KRON $9,192,000.00
  • FBLG N/A
  • Revenue This Year
  • KRON N/A
  • FBLG N/A
  • Revenue Next Year
  • KRON N/A
  • FBLG N/A
  • P/E Ratio
  • KRON N/A
  • FBLG N/A
  • Revenue Growth
  • KRON 21.16
  • FBLG N/A
  • 52 Week Low
  • KRON $0.65
  • FBLG $0.70
  • 52 Week High
  • KRON $1.60
  • FBLG $6.70
  • Technical
  • Relative Strength Index (RSI)
  • KRON 64.27
  • FBLG 34.55
  • Support Level
  • KRON $0.87
  • FBLG $0.70
  • Resistance Level
  • KRON $0.90
  • FBLG $0.99
  • Average True Range (ATR)
  • KRON 0.02
  • FBLG 0.09
  • MACD
  • KRON 0.01
  • FBLG -0.01
  • Stochastic Oscillator
  • KRON 87.65
  • FBLG 0.00

About KRON Kronos Bio Inc.

Kronos Bio Inc is a clinical-stage biopharmaceutical company. It is focused on the discovery and development of small molecule therapeutics to address deregulated transcription, a hallmark of cancer and autoimmune diseases.

About FBLG FIBROBIOLOGICS INC

FibroBiologics Inc is a clinical-stage cell therapy company focused on developing and commercializing fibroblast-based therapies for patients suffering from chronic diseases with significant unmet medical needs, including degenerative disc disease, multiple sclerosis, wound healing, and certain cancers, and potential extension of life applications including thymic and splenic involution reversal.

Share on Social Networks: